995861
Among patients with atrial high-rate episodes detected by implantable devices, anticoagulation with edoxaban did not show a benefit but did increase bleeding risk in the NOAH-AFNET 6 trial.
Source: medscape.com
Stay updated with breaking news from Implications For Wearable Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Among patients with atrial high-rate episodes detected by implantable devices, anticoagulation with edoxaban did not show a benefit but did increase bleeding risk in the NOAH-AFNET 6 trial.